Cita APA (7a ed.)

Cantini, G., Fei, L., Canu, L., Lazzeri, E., Sottili, M., Francalanci, M., . . . Luconi, M. (2021). Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG.

Cita Chicago Style (17a ed.)

Cantini, Giulia, et al. Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG, 2021.

Cita MLA (8a ed.)

Cantini, Giulia, et al. Stimulated Expression of CXCL12 in Adrenocortical Carcinoma by the PPARgamma Ligand Rosiglitazone Impairs Cancer Progression. MDPI AG, 2021.